Powered by

House Oversight & Reform Committee Sets Hearing on Unsustainable Drug Prices Part 2

Sep 30, 2020 - Targeted News Service

The House Oversight and Reform Committee issued the following information for a hearing entitled: "Unsustainable Drug Prices: Testimony from the CEOs Part II" at 10 a.m. on Oct. 1 at 2154 Rayburn House Office Building, Washington, DC 20515:

Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, announced that the Committee will hold two days of hearings with top executives of major drug companies to examine their pricing practices for some of the costliest drugs ...